← Open Payments lookup

DANIEL MARSHALL: Open Payments

NPI 1073248829 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$518 in 25 payments from 8 companies in 2025. Trend: 2023 $34 · 2024 $557 · 2025 $518

Food & beverage: $518
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.10$251
Otsuka America Pharmaceutical, Inc.4$83
Alkermes, Inc.3$60
Teva Pharmaceuticals USA, Inc.2$34
Corium, LLC3$34
Neurocrine BioSciences, Inc.1$22
Tris Pharma Inc1$18
Axsome Therapeutics, Inc.1$15

Products named: FANAPT, REXULTI, ARISTADA, AUSTEDO XR, Azstarys, INGREZZA, Dyanavel XR, Auvelity.

Industry payments across ID — which companies pay providers there.